By collecting data from TCGA, combined with statistical analysis, the investigators not only identified aberrantly expressed M6A regulators in ccRCC, but also uncovered significant relationships between them and clinical features and established risk profiles to predict prognosis of ccRCC [187, 188]. This evidence concerns the gene METTL3 and nonpapillary renal cell carcinoma.